Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
BMC Neurology|May 13, 2010
Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case reportHilde M H Braakman, Jan Lodder, Alida A Postma, et al.European Journal of Internal Medicine|January 18, 2011
Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortalityDaniël A Geerse, Lambert F R Span, Sara-Joan Pinto-Sietsma, et al.Leukemia Research|July 31, 2007
Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactionsLambert F R Span, Eugenie Rutten, Anita Gemmink, et al.Annals of Hematology|April 13, 2010
Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the NetherlandsJeroen P Jansen, Amy K O'Sullivan, Elly Lugtenburg, et al.Experimental Hematology|March 23, 2005
Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cellsLambert F R Span, Gertie Vierwinden, Arie H Pennings, et al.European Journal of Haematology|August 30, 2008
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the NetherlandsWiro B Stam, Amy K O'Sullivan, Bart Rijnders, et al.Clinical and Translational Science|July 16, 2024
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazoleSylvia D Klomp, Anette Veringa, Jan-Willem C Alffenaar, et al.Current Fungal Infection Reports|July 1, 2016
Therapeutic Drug Monitoring of Posaconazole: an UpdateBart G J Dekkers, Martijn Bakker, Kim C M van der Elst, et al.BMJ Open|January 10, 2020
Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic reviewAnne-Grete Märtson, Martijn Bakker, Hans Blokzijl, et al.International Journal of Antimicrobial Agents|December 26, 2016
Bioavailability of voriconazole in hospitalised patientsAnette Veringa, Sanne Geling, Lambert F R Span, et al.Pageof 3